Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

NT Pharma

    • Home
    • NT Pharma
Company Deals

China NT Pharma Group Enters MOU with Global Fund to Expand Orthopedic Product Line

Fineline Cube Oct 10, 2023

China NT Pharma Group Company Ltd (HKG: 1011), a China-based pharmaceutical company, has announced the...

Company Deals

China NT Pharma Group Inks Licensing Deal for Orticumab in Asia

Fineline Cube Jun 22, 2022

China-based China NT Pharma Group Company Ltd (HKG: 1011) has announced a licensing agreement with...

Company Deals

China NT Pharma Group Company Ltd Inks Licensing Deal for Monoclonal Antibodies

Fineline Cube Jun 15, 2022

China-based China NT Pharma Group Company Ltd (HKG: 1011) has announced a potential acquisition agreement...

Recent updates

  • Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint
  • Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures
  • Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes
  • Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod
  • TransThera Tinengotinib Cholangiocarcinoma Priority Review China
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.